TY - JOUR
T1 - Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis
AU - Ueda, Sho
AU - Oryoji, Daisuke
AU - Yamamoto, Ken
AU - Noh, Jaeduk Yoshimura
AU - Okamura, Ken
AU - Noda, Mitsuhiko
AU - Kashiwase, Koichi
AU - Kosuga, Yuka
AU - Sekiya, Kenichi
AU - Inoue, Kaori
AU - Yamada, Hisakata
AU - Oyamada, Akiko
AU - Nishimura, Yasuharu
AU - Yoshikai, Yasunobu
AU - Ito, Koichi
AU - Sasazuki, Takehiko
PY - 2014/2
Y1 - 2014/2
N2 - Background: Autoimmune thyroid disease (AITD) includes Graves disease (GD) and Hashimoto thyroiditis (HT), which partially share immunological features. Determining the genetic basis that distinguishesGDandHTis a key to understanding the differences between these 2 related diseases. Aim: The aims of this study were to identifyHLAantigens that can explain the immunopathological difference between GD and HT and to elucidate epistatic interactions between protective and susceptible HLA alleles, which can delineate the distinct function of HLA in AITD etiology. Design:Wegenotyped 991 patients with AITD (547 patients withGDand 444 patients with HT) and 481 control subjects at the HLA-A, HLA-C, HLA-B, DRB1, DQB1, and DPB1 loci. A direct comparison of HLA antigen frequencies between GD and HT was performed. We further analyzed an epistatic interaction between the susceptible and protective HLA alleles in the development of GD and HT. Results: We identified 4 and 2 susceptible HLA molecules primarily associated with GD and HT, respectively, HLA-B*35:01, HLA-B*46:01, HLA-DRB1*14:03, and HLA-DPB1*05:01 for GD and HLAA* 02:07 and HLA-DRB4 for HT. In a direct comparison between GD and HT, we identified GDspecific susceptible class II molecules, HLA-DP5 (HLA-DPB1*05:01; Pc = 1.0×10-9) and HLA-DR14 (HLA-DRB*14:03; Pc =.0018). In contrast, HLA components on 3 common haplotypes in Japanese showed significant protective effects against the development of GD and HT (HLA-A*24:02- C*12: 02-B*52:01-DRB1*15:02-DQB1*06:01-DPB1*09:01 and HLA-A*24:02-C*07:02-B*07:02-DRB1*01: 01-DQB1*05:01-DPB1*04:02 haplotypes for GD and HLA-A*33:03- C*14:03-B*44:03-DRB1*13:02- DQB1*06:04-DPB1*04:01 haplotype for GD and HT). Interestingly, the representative protective HLA, HLA-DR13 (HLA-DRB1*13:02), was epistatic to susceptible HLA-DP5 in controlling the development of GD. Conclusion: We show that HLA exerts a dual function, susceptibility and resistance, in controlling the development of GD and HT. We also show that the protective HLA allele is partially epistatic to the susceptible HLA allele in GD.
AB - Background: Autoimmune thyroid disease (AITD) includes Graves disease (GD) and Hashimoto thyroiditis (HT), which partially share immunological features. Determining the genetic basis that distinguishesGDandHTis a key to understanding the differences between these 2 related diseases. Aim: The aims of this study were to identifyHLAantigens that can explain the immunopathological difference between GD and HT and to elucidate epistatic interactions between protective and susceptible HLA alleles, which can delineate the distinct function of HLA in AITD etiology. Design:Wegenotyped 991 patients with AITD (547 patients withGDand 444 patients with HT) and 481 control subjects at the HLA-A, HLA-C, HLA-B, DRB1, DQB1, and DPB1 loci. A direct comparison of HLA antigen frequencies between GD and HT was performed. We further analyzed an epistatic interaction between the susceptible and protective HLA alleles in the development of GD and HT. Results: We identified 4 and 2 susceptible HLA molecules primarily associated with GD and HT, respectively, HLA-B*35:01, HLA-B*46:01, HLA-DRB1*14:03, and HLA-DPB1*05:01 for GD and HLAA* 02:07 and HLA-DRB4 for HT. In a direct comparison between GD and HT, we identified GDspecific susceptible class II molecules, HLA-DP5 (HLA-DPB1*05:01; Pc = 1.0×10-9) and HLA-DR14 (HLA-DRB*14:03; Pc =.0018). In contrast, HLA components on 3 common haplotypes in Japanese showed significant protective effects against the development of GD and HT (HLA-A*24:02- C*12: 02-B*52:01-DRB1*15:02-DQB1*06:01-DPB1*09:01 and HLA-A*24:02-C*07:02-B*07:02-DRB1*01: 01-DQB1*05:01-DPB1*04:02 haplotypes for GD and HLA-A*33:03- C*14:03-B*44:03-DRB1*13:02- DQB1*06:04-DPB1*04:01 haplotype for GD and HT). Interestingly, the representative protective HLA, HLA-DR13 (HLA-DRB1*13:02), was epistatic to susceptible HLA-DP5 in controlling the development of GD. Conclusion: We show that HLA exerts a dual function, susceptibility and resistance, in controlling the development of GD and HT. We also show that the protective HLA allele is partially epistatic to the susceptible HLA allele in GD.
UR - http://www.scopus.com/inward/record.url?scp=84893723685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893723685&partnerID=8YFLogxK
U2 - 10.1210/jc.2013-2841
DO - 10.1210/jc.2013-2841
M3 - Article
C2 - 24285682
AN - SCOPUS:84893723685
SN - 0021-972X
VL - 99
SP - E379-E383
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 2
ER -